Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
Methods in Molecular Biology (Clifton, N.J.)
|
July 12, 2017
Identifying and Validating Tankyrase Binders and Substrates: A Candidate Approach
Katie Pollock, Michael Ranes, Ian Collins, et al.
Molecular Cell
|
August 5, 2021
Reconstitution of the destruction complex defines roles of AXIN polymers and APC in β-catenin capture, phosphorylation, and ubiquitylation
Michael Ranes, Mariola Zaleska, Saira Sakalas, et al.
Biochimica Et Biophysica Acta
|
March 31, 2007
The ins and outs of ATP-dependent chromatin remodeling in budding yeast: biophysical and proteomic perspectives
Joke J F A van Vugt, Michael Ranes, Coen Campsteijn, et al.
Molecular and Cellular Biology
|
December 15, 2010
New suppressors of THO mutations identify Thp3 (Ypr045c)-Csn12 as a protein complex involved in transcription elongation
Sonia Jimeno, Cristina Tous, María L García-Rubio, et al.
Molecular Cell
|
August 6, 2016
Tankyrase Requires SAM Domain-Dependent Polymerization to Support Wnt-β-Catenin Signaling
Laura Mariotti, Catherine M Templeton, Michael Ranes, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 25, 2014
Dysregulation of gene expression as a cause of Cockayne syndrome neurological disease
Yuming Wang, Probir Chakravarty, Michael Ranes, et al.
Nucleic Acids Research
|
April 10, 2016
A ubiquitylation site in Cockayne syndrome B required for repair of oxidative DNA damage, but not for transcription-coupled nucleotide excision repair
Michael Ranes, Stefan Boeing, Yuming Wang, et al.
Nature Communications
|
May 12, 2018
Genome-wide and high-density CRISPR-Cas9 screens identify point mutations in PARP1 causing PARP inhibitor resistance
Stephen J Pettitt, Dragomir B Krastev, Inger Brandsma, et al.
Journal for Immunotherapy of Cancer
|
April 16, 2019
CEA expression heterogeneity and plasticity confer resistance to the CEA-targeting bispecific immunotherapy antibody cibisatamab (CEA-TCB) in patient-derived colorectal cancer organoids
Reyes Gonzalez-Exposito, Maria Semiannikova, Beatrice Griffiths, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
Methods in Molecular Biology (Clifton, N.J.)
|
July 12, 2017
Identifying and Validating Tankyrase Binders and Substrates: A Candidate Approach
Katie Pollock, Michael Ranes, Ian Collins, et al.
Molecular Cell
|
August 5, 2021
Reconstitution of the destruction complex defines roles of AXIN polymers and APC in β-catenin capture, phosphorylation, and ubiquitylation
Michael Ranes, Mariola Zaleska, Saira Sakalas, et al.
Biochimica Et Biophysica Acta
|
March 31, 2007
The ins and outs of ATP-dependent chromatin remodeling in budding yeast: biophysical and proteomic perspectives
Joke J F A van Vugt, Michael Ranes, Coen Campsteijn, et al.
Molecular and Cellular Biology
|
December 15, 2010
New suppressors of THO mutations identify Thp3 (Ypr045c)-Csn12 as a protein complex involved in transcription elongation
Sonia Jimeno, Cristina Tous, María L García-Rubio, et al.
Molecular Cell
|
August 6, 2016
Tankyrase Requires SAM Domain-Dependent Polymerization to Support Wnt-β-Catenin Signaling
Laura Mariotti, Catherine M Templeton, Michael Ranes, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 25, 2014
Dysregulation of gene expression as a cause of Cockayne syndrome neurological disease
Yuming Wang, Probir Chakravarty, Michael Ranes, et al.
Nucleic Acids Research
|
April 10, 2016
A ubiquitylation site in Cockayne syndrome B required for repair of oxidative DNA damage, but not for transcription-coupled nucleotide excision repair
Michael Ranes, Stefan Boeing, Yuming Wang, et al.
Nature Communications
|
May 12, 2018
Genome-wide and high-density CRISPR-Cas9 screens identify point mutations in PARP1 causing PARP inhibitor resistance
Stephen J Pettitt, Dragomir B Krastev, Inger Brandsma, et al.
Journal for Immunotherapy of Cancer
|
April 16, 2019
CEA expression heterogeneity and plasticity confer resistance to the CEA-targeting bispecific immunotherapy antibody cibisatamab (CEA-TCB) in patient-derived colorectal cancer organoids
Reyes Gonzalez-Exposito, Maria Semiannikova, Beatrice Griffiths, et al.
Page
of 1